Patients were treated with 16 weeks and magnetic resonance imaging (MRI)-proton density fat fraction [MRI-PDFF] and homeostasis model assessment of insulin resistance [HOMA-IR]) and homeostasis model assessment of insulin resistance (HOMA-IR) fibro-inflammation markers (alanine aminotransferase [ALT], corrected T1 [cT1], keratin-18 [K-18] M65, and N-terminal type III collagen pro-peptide [Pro-C3]) was applied. This evidence concerns the gene KRT18 and Insulin resistance.